CVS Health Corporation has announced impressive financial results for 2021, with revenues of approximately $291 billion and a net income of about $8 billion. The company's stock has surged 90% since March 2020, outperforming the broader market. Alongside these financial gains, CVS has enhanced safety by installing time delay safes, achieving a 70% reduction in pharmacy robberies in specific locations. Looking ahead, CVS is expected to report quarterly earnings of $2.14 per share on May 4, 2022, as it continues to invest in healthcare technology.